Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Nomogram for predicting survival in men with clinically localized prostate cancer who do not undergo definitive therapy

Nature Clinical Practice Urology volume 5, pages 362–363 (2008)Cite this article

boxed-textKattan MW et al. (2008) Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer 112: 69–74

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bill-Axelson A et al. (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352: 1977–1984

    Article  CAS  Google Scholar 

  2. Studer UE et al. (2008) Using PSA to guide timing of androgen deprivation in patients with T0–4 N0–2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 53: 941–949

    Article  Google Scholar 

  3. Klotz L (2005) Active surveillance for prostate cancer: for whom? J Clin Oncol 23: 8165–8169

    Article  Google Scholar 

  4. Steyerberg EW et al. (2007) Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 177: 107–112

    Article  CAS  Google Scholar 

  5. Nakanishi H et al. (2007) A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance. Cancer 110: 2441–2447

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Division of Urology, University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, MG 408, Toronto, ON M4N 3M5, Canada laurence.klotz@sunnybrook.ca

Authors and Affiliations

  1. L Klotz is a Professor of Surgery at the University of Toronto, and the Chief of Urology at the Sunnybrook Health Sciences Centre, Toronto, ON, Canada.,

    Laurence Klotz

Authors
  1. Laurence Klotz
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klotz, L. Nomogram for predicting survival in men with clinically localized prostate cancer who do not undergo definitive therapy. Nat Rev Urol 5, 362–363 (2008). https://doi.org/10.1038/ncpuro1131

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1131

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing